Apella Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Apella Capital's ELV Position: Q3 2026 in Review
Apella Capital increased its Elevance Health (ELV) stake by 14% in Q3 2026, buying an estimated $170K and bringing the position to 3,357 shares worth $1.36M. The position accounts for 0.02% of the portfolio, ranked #348.
Apella Capital first reported a position in ELV in Q1 2022 and has held it in 15 quarters since. 1,615 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- Apella Capital held 3,357 shares of Elevance Health worth $1.36M as of Q3 2026.
- Apella Capital bought 425 Elevance Health shares in Q3 2026, an estimated $170K.
- Elevance Health made up 0.02% of Apella Capital's portfolio in Q3 2026, its #348 holding.
- Apella Capital first reported a position in Elevance Health in Q1 2022 and has held it in 15 quarters since.
- 1,615 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on Apella Capital's 13F filing for Q3 2026, filed 8 Oct 2026.